Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 69: 1397-1401, 1990;
8750-7587/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brechue, W. F.
Right arrow Articles by Lukaski, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brechue, W. F.
Right arrow Articles by Lukaski, H. C.

Journal of Applied Physiology, Vol 69, Issue 4 1397-1401, Copyright © 1990 by American Physiological Society

ARTICLES

Body water and electrolyte responses to acetazolamide in humans

W. F. Brechue, J. M. Stager and H. C. Lukaski
Human Performance Laboratory, Indiana University, Bloomington 47405.

Acetazolamide (ACZ), a potent carbonic anhydrase inhibitor, is a known diuretic and causal agent in metabolic acidosis. Its diuretic qualities are well established with respect to urine flow and electrolyte excretion. However, the impact of ACZ on body hydration status has not been adequately quantified. Thus, to establish the influence of ACZ treatment on body water, nine healthy males were evaluated for hydration status after clinically prescribed doses of ACZ. The drug was administered in three 250-mg oral doses 14, 8, and 2 h before determination of body water compartments. ACZ led to a significant 1.7-liter reduction in total body water (3.4%). A significant reduction in extracellular water of 3.3 liters is partitioned as the loss of total body water and a significant increase in intracellular water (1.6 liters). Venous blood pH and plasma HCO3- were significantly reduced 0.09 units and 5.9 mM, respectively, with ACZ. Plasma protein concentration was increased, but plasma osmolality did not change. Plasma Na+, K+, and Cl- concentrations were not different with ACZ, but total electrolyte content was significantly decreased 45.2, 1.17, and 44.1 meq, respectively, for all three. Urine K+, HCO3-, flow, and pH were elevated after ACZ treatment, whereas Na+ and Cl- were the same as placebo levels. In conclusion, acute clinical doses of ACZ reduce body fluid compartments, leading to a moderate isosmotic hypovolemia with an intracellular volume expansion as well as metabolic acidosis.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
V. Faoro, S. Huez, S. Giltaire, A. Pavelescu, A. van Osta, J.-J. Moraine, H. Guenard, J.-B. Martinot, and R. Naeije
Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes
J Appl Physiol, October 1, 2007; 103(4): 1161 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
F H Zaidi and P E Kinnear
Acetazolamide, alternate carbonic anhydrase inhibitors and hypoglycaemic agents: comparing enzymatic with diuresis induced metabolic acidosis following intraocular surgery in diabetes
Br. J. Ophthalmol., May 1, 2004; 88(5): 714 - 715.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
B. W. Scheuermann, J. M. Kowalchuk, D. H. Paterson, A. W. Taylor, and H. J. Green
Muscle metabolism during heavy-intensity exercise after acute acetazolamide administration
J Appl Physiol, February 1, 2000; 88(2): 722 - 729.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online